Showing results (1761-1770 of 5,275) with videos related to

Sort By:
Pageof 528
Oncology|January 1, 1991
Effects of carotenoid administration on bladder cancer preventionM M Mathews-Roth, N Lausen, G Drouin, et al.
Oncology|November 27, 2008
Rituximab in lymphocyte-predominant Hodgkin diseaseHatem A Azim, Giancarlo Pruneri, Emilia Cocorocchio, et al.
Oncology|November 27, 2008
Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapyIrina Jiveliouk, Benjamin Corn, Moshe Inbar, et al.
Oncology|November 27, 2008
Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancerDaisuke Takahari, Yasuhide Yamada, Natuko T Okita, et al.
Oncology|January 29, 2009
Prevalence of single and multiple human papillomavirus types in cervical cancer and precursor lesions in Hubei, ChinaHong Bing Cai, Xiao Hua Ding, Chang Chun Chen
Oncology|February 28, 2009
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancersMaria S Pino, Michele Milella, Alain Gelibter, et al.
Oncology|January 6, 2009
Erlotinib for metastatic non-small-cell lung cancer: first-, second- or third-line setting - does it matter ? A single-institution experienceSikander Ailawadhi, Lyudmyla Derby, Raj Natarajan, et al.
Oncology|June 27, 2009
Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancerYoshihiro Kakeji, Eiji Oki, Akinori Egashira, et al.
Oncology|July 3, 2009
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experienceJames D Cox, Sergio A Giralt, Mary L Veazie, et al.
Oncology|July 25, 2009
Good response to paclitaxel predicts high rates of pathologic complete response for breast cancer patients treated preoperatively with paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamideSeung Jin Kim, Tetsuya Taguchi, Kenzo Shimazu, et al.
Pageof 528